Product Dossier
AURO-CITALOPRAM
Product Dossier for AURO-CITALOPRAM (citalopram, Strides Pharma Science). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Strides Pharma Science
- Active ingredient: citalopram
- Therapeutic area: Psychiatry
- Related brand: CELAPRAM
- Related brand: APX-CITALOPRAM
- Related brand: IPC
- Same area: REXULTI
- Same area: NICORETTE
What it is
AURO-CITALOPRAM is a film-coated tablet containing citalopram as the hydrobromide salt, available in 10 mg, 20 mg and 40 mg strengths.
Regulatory history
AURO-CITALOPRAM was first listed on the Australian Register of Therapeutic Goods on 11 January 2010. ---
**Note:** The provided source document contains only ARTG registration details. Information regarding approved indications, dosing, safety warnings, contraindications, and PBS listing is not available in the supplied documentation and therefore cannot be included in this dossier.